Read the University of Dundee’s feature story: Collaboration with Boehringer Ingelheim: A world-changing idea: the development a completely new class of drugs with the potential to “drug the undruggable” Previous Post Our dual Brd7/9 PROTAC degrader VZ185 Next Post Funding success for our Lab's TPD spinout company Amphista therapeutics
